Continuing Professional Development – Radiation Therapy
Maximise your CPD by reading the following selected article and answer the five questions. Please remember to self-claim your CPD and retain your supporting evidence. Answers will be available via the QR code and online at www.asmirt.org/news-and-publications/jmrs, as well as published in JMRS – Volume 68, Issue 4, December 2021.
Radiation Therapy – Original Article
Visualising the urethra for prostate radiotherapy planning
- To facilitate high resolution multiplane viewing of MRI prostate images in a treatment planning system, the MRI sequences should be acquired with:
- Isotropic voxels
- An in-dwelling catheter
- A 1.5T scanner
- 3mm slice thickness
- The 3D T2 SPACE (Sampling Perfection with Application optimised Contrast using different flip angle Evolution) series in this study had which Time to Repetition (TR) parameter?
- 8030 ms
- 1700 ms
- 689 ms
- 1100 ms
- Dice Similarity Coefficient (DSC) scores were used to assess urethra planning organ at risk volume (PRV) overlap between observers. DSC is reported as a number between 0 representing no spatial overlap and 1 representing perfect spatial overlap. What was the mean DSC for the 3D T2 SPACE series?
- 0.15
- 0.47
- 0.62
- 0.78
- Which of the following describes the appearance of the urethra on a T2 weighted MRI sequence compared to the surrounding glandular tissue?
- Hypo-intense
- Hyper-intense
- Homogenous
- Void of signal
- Which patient factor negatively impacts urethra visualisation on a 3D T2 SPACE series?
- Trans-urethral resection of the prostate (TURP) voids
- Anatomically straight and level pelvis
- Large body habitus
- Suitable bowel preparation
- Rai R, Kumar S, Batumalai V, Elwadia D, Ohanessian L, Juresic E, et. al. The integration of MRI in radiation therapy: collaboration of radiographers and radiation therapists. J Med Radiat Sci 2017; 64(1): 61-68.
- Das IJ, McGee KP, Tyagi N, Wang H. Role and future of MRI in radiation oncology. Br J Radiol 2019; 20180505.
- Kerkmeijer LGW, Groen VH, Pos FJ, Haustermans K, Monninkhof EM, Smeenk RJ, et. al. Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III trial. J Clin Oncol 2021; 39(7): 787-796.
Answers
Scan this QR code to find the answers, or visit www.asmirt.org/news-and-publications/jmrs